| Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | OR | CI 95% | p | OR | CI 95% | p | OR | CI 95% | p | OR | CI 95% | P | OR | CI 95% | p | OR | CI95% | p |
Age (years) | ||||||||||||||||||
  < 79 | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
 79–83 | 1.49 | (1.11–2.00) | 0.008* | 1.53 | (1.14–2.06) | 0.005* | 1.58 | (1.17–2.14) | 0.003* | 1.52 | (1.12–2.06) | 0.007* | 1.58 | (1.15–2.18) | 0.005* | 1.56 | (1.13–2.14) | 0.007* |
 83–87 | 1.99 | (1.48–2.65) | < 0.001* | 2.03 | (1.50–2.75) | < 0.001* | 2.10 | (1.55–2.85) | < 0.001* | 1.84 | (1.35–2.52) | < 0.001* | 1.84 | (1.33–2.55) | < 0.001* | 1.86 | (1.34–2.57) | < 0.001* |
  > 87 | 3.80 | (2.80–5.12) | < 0.001* | 3.85 | (2.80–5.28) | < 0.001* | 4.03 | (2.92–5.56) | 0.000* | 3.45 | (2.49–4.79) | 0.000* | 3.20 | (2.27–4.49) | < 0.001* | 3.23 | (2.29–4.55) | < 0.001* |
Sex | ||||||||||||||||||
 Male | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
 Female | 1.41 | (1.12–1.77) | 0.004* | 1.42 | (1.13–1.79) | 0.003* | 1.48 | (1.17–1.88) | 0.001* | 1.48 | (1.16–1.88) | 0.001* | 1.44 | (1.13–1.85) | 0.004* | 1.48 | (1.14–1.92) | 0.003* |
Hemoglobin count (g/dl) | 0.78 | (0.72–0.85) | < 0.001* | 0.79 | (0.73–0.86) | < 0.001* | 0.81 | (0.75–0.89) | < 0.001* | 0.82 | (0.75–0.89) | < 0.001* | 0.86 | (0.79–0.94) | 0.001* | 0.86 | (0.79–0.94) | 0.001* |
Kidney function (eGFR) | ||||||||||||||||||
 Normal |  |  |  | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
 Mild decrease |  |  |  | 0.75 | (0.51–1.10) | 0.14 | 0.75 | (0.51–1.11) | 0.15 | 0.77 | (0.52–1.15) | 0.20 | 0.80 | (0.53–1.21) | 0.30 | 0.82 | (0.54–1.25) | 0.36 |
 Moderate to severe decrease |  |  |  | 0.82 | (0.53–1.25) | 0.36 | 0.81 | (0.52–1.24) | 0.33 | 0.84 | (0.54–1.30) | 0.43 | 0.88 | (0.56–1.40) | 0.60 | 0.90 | (0.57–1.44) | 0.67 |
 Severe decrease |  |  |  | 0.92 | (0.40–2.08) | 0.84 | 0.82 | (0.36–1.87) | 0.64 | 0.86 | (0.37–1.99) | 0.72 | 0.84 | (0.35–2.00) | 0.70 | 0.80 | (0.34–1.91) | 0.62 |
Inflammation status (CRP) | ||||||||||||||||||
 No inflammation |  |  |  |  |  |  | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
 Inflammation |  |  |  |  |  |  | 2.25 | (1.58–3.20) | < 0.001* | 2.26 | (1.58–3.25) | < 0.001* | 2.11 | (1.45–3.07) | < 0.001* | 2.12 | (1.45–3.09) | < 0.001* |
Cognitive (MMSE) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 No impairment |  |  |  |  |  |  |  |  |  | 1 |  |  | 1 |  |  | 1 |  |  |
 Mild impairment |  |  |  |  |  |  |  |  |  | 1.74 | (1.36–2.22) | < 0.001* | 1.53 | (1.18–1.98) | 0.001* | 1.44 | (1.10–1.87) | 0.007* |
 Moderate impairment |  |  |  |  |  |  |  |  |  | 2.27 | (1.68–3.08) | < 0.001* | 1 .81 | (1.32–2.50) | < 0.001* | 1.65 | (1.18–2.31) | 0.003* |
 Severe impairment |  |  |  |  |  |  |  |  |  | 4.29 | (1.60–11.51) | 0.004* | 1.98 | (0.71–5.51) | 0.19 | 1.72 | (0.62–4.81) | 0.30 |
Nutritional status (MNA) | ||||||||||||||||||
 Normal |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  | 1 |  |  |
 Risk of malnutrition |  |  |  |  |  |  |  |  |  |  |  |  | 3.23 | (2.53–4.11) | 0.000* | 3.24 | (2.55–4.13) | < 0.001* |
 Malnutrition |  |  |  |  |  |  |  |  |  |  |  |  | 8.21 | (4.03–16.74) | 0.000* | 8.15 | (4.00–16.60) | < 0.001* |
School education level | ||||||||||||||||||
 Low level of education |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |
 Middle level of education |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.91 | (0.70–1.18) | 0.47 |
 High level of education |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.69 | (0.50–0.95) | 0.025* |
Living arrangements | ||||||||||||||||||
 Living alone |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |
 Living with others |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.80 | (0.63–1.01) | 0.06 |